Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
WuXi AppTec
Sort By
Newest First
1 / 2
1 / 2
WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
WuXi AppTec
PR-M11-20-040
March 02, 2021
Capacity Expansion
WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory
WuXi AppTec
PR-M11-20-019
November 19, 2020
CAR-T Cell Therapy
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
WuXi Advanced Therapies
PR-M05-20-NI-025
May 18, 2020
Expanded Capacity
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
WuXi STA
PR-M01-20-NI-010
January 07, 2020
Collaboration
Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects
Nice Insight
PR-M05-19-NI-073
May 24, 2019
M&A
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
WuXi AppTec
PR-M05-19-NI-030
May 10, 2019
Healthcare
The First WuXi Healthcare Forum Opens in Shanghai
WuXi AppTec Group
PR-M03-19-NI-019
March 06, 2019
Growth
WuXi AppTec Plans for Growth
Emilie Branch
Pharma's Almanac
PAO-M12-18-NI-005-10
December 11, 2018
Awards
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
WuXi AppTec
PR-M12-18-NI-008
December 04, 2018
Announcement
WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance
WuXi AppTec
PR-M10-18-NI-029
October 09, 2018
Artificial Intelligence
WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies
WuXi AppTec
PR-M09-18-NI-054
September 19, 2018
Drug Approval
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
WuXi AppTec
PR-M06-18-NI-057
June 18, 2018
Artificial Intelligence
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
WuXi AppTec
PR-M06-18-NI-037
June 12, 2018
Novel Medicine
WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients
WuXi AppTec
PAO-M05-18-CL-004
May 25, 2018
IPO
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
WuXi AppTec
PR-M05-18-NI-037
May 08, 2018
Expanded Capacity
WuXi STA to Build a New R&D Center in Shanghai
WuXi AppTec
PR-M05-18-NI-001
May 01, 2018
Drug Candidate
STA Pharmaceutical Co. to Manufacture Phoenix Molecular Designs’ Anticancer Candidate
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-18-NI-018
April 26, 2018
Expanded Capacity
WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services
WuXi AppTec
PR-M04-18-NI-75
April 19, 2018
Partnership
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies
WuXi AppTec
PR-M03-18-NI-090
March 26, 2018
Genomics
WuXi NextCODE Unveils Genomics Partnership with Google Cloud
WuXi NextCODE
PR-M03-18-NI-036
March 09, 2018
